Max BioPharma: Funding, Investors & Team (Sep 2026)
MAX BioPharma is a California-based biotechnology firm developing novel small molecule lipids, referred to as oxysterols, as candidates for therapeutic drugs for debilitating and fatal human diseases. These oxysterol molecules belong to the family of sterols that have the ability to stimulate bone growth, block the growth of cancer cells, and inhibit their ability to metastasize.
Max BioPharma has raised $13.0M across 1 funding round on record, the most recent a Series A of $13.0M announced in Mar 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Max BioPharma Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Max BioPharma Funding Rounds
Max BioPharma Founders and Leadership Team
Contact details for the Max BioPharma team: 1 has a LinkedIn profile.
Start 14-day free trial →Max BioPharma Funding Compared to Other Biotechnology Startups
Max BioPharma's latest round of $13.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Biotechnology Startups Like Max BioPharma
Companies Similar to Max BioPharma
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…
Wren Bioscience is developed to give rapid, reliable bacterial identification anywhere milk safety is…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
Amyl therapeutics is a preclinical-stage biotechnology company pioneering a breakthrough approach to treating…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
Max BioPharma Funding FAQs
What does Max BioPharma do?
MAX BioPharma is a California-based biotechnology firm developing novel small molecule lipids, referred to as oxysterols, as candidates for therapeutic drugs for debilitating and fatal human diseases. These oxysterol molecules belong to the family of sterols that have the ability to stimulate bone growth, block the growth of cancer cells, and inhibit their ability to metastasize.
How much funding has Max BioPharma raised?
Max BioPharma has raised $13.0M across 1 round on record. The most recent is a Series A of $13.0M announced in Mar 2026.
When did Max BioPharma last raise funding?
Max BioPharma's most recent funding round on record is a Series A of $13.0M, announced in Mar 2026.
Who founded Max BioPharma?
FundedIQ lists Farhad Parhami (Founder) at Max BioPharma.
How many employees does Max BioPharma have?
Max BioPharma is in the 11-50 employee band.
How does Max BioPharma's funding compare to other Biotechnology startups?
Max BioPharma's latest round of $13.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Max BioPharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Max BioPharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.